Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON39831
NL-OMON39831
Completed
Phase 3

SYMPATHY: Renal sympathetic denervation as a new treatment for therapy resistant hypertension. - SYMPATHY

niversitair Medisch Centrum Utrecht0 sites570 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionshypertensiehigh blood pressurehypertension10038430

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
hypertensie
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
570
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • •1\.Individual has an average 24\-hour SBP of \>\= 130 mmHg or a mean day\-time SBP \>\= 135 mmHg, as determined with the use of ABPM, while the patient uses 3 or more antihypertensive agents or with documented intolerance to 2 or more of the 4 major classes antihypertensive drugs
  • •(ACE/ARB, Calcium channel blocker, Beta Blocker, Diuretic) and no possibility to take 3 anti\-hypertensive drugs.
  • •2\.Individual is \>\=18 years of age.

Exclusion Criteria

  • •1\.Individual has a treatable secondary cause of hypertension
  • •2\.Individual has an eGFR below 1\. Individual has a treatable secondary cause of hypertension 3\.Individual has renal artery anatomy that is ineligible for treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials

Withdrawn
Not Applicable
SYMPATHY: Renal sympathetic denervation as a new treatment for therapy resistant hypertension: from rescue to resolve.hoge bloeddrukhypertension high blood pressure10038430
NL-OMON37568niversitair Medisch Centrum Utrecht260
Completed
Phase 2
Denervation of the renal sympathetic nerves in heart failure with normal LV ejection fraction.heartfailurehigh blood pressure1001928010057166
NL-OMON39827niversitair Medisch Centrum Utrecht16
Active, not recruiting
Not Applicable
/A
EUCTR2012-001066-14-ESConsorci Mar Parc de salut de Barcelona ( Parc de Salut Mar)
Withdrawn
Phase 4
Renal Sympathetic Denervation in patients with therapy-resistant Catecholamine Polymorphic Ventricular Tachycardia (CPVT) and Long QT Syndrome (LQTS) * RESIDENT Study
NL-OMON41010Academisch Medisch Centrum20
Withdrawn
Not Applicable
Sympathy Redo: redo of renal denervation with a second generation device.hypertensiehigh blood pressurehypertension10038430
NL-OMON42639niversitair Medisch Centrum Utrecht30